Bedaquiline and delamanid in combination for treatment of drug-resistant tuberculosis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference4 articles.
1. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study;Ferlazzo;Lancet Infect Dis,2018
2. Safety and efficacy of exposure to bedaquiline-delamanid in MDR-TB: a case series from France and Latvia;Guglielmetti;Eur Respir J,2018
3. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis;Alffenaar;Lancet,2018
4. Compassionate use of delamanid in combination wtih bedaquiline for the treatment of MDR-TB;Hafkin;Eur Respir J,2019
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia;The International Journal of Mycobacteriology;2024-04
2. Omics-Based Approaches in Developing Treatments Against Antimicrobial Resistance;Antimicrobial Resistance: Factors to Findings;2024
3. An Insight on the Prospect of Quinazoline and Quinazolinone Derivatives as Anti-tubercular Agents;Current Organic Synthesis;2023-12
4. Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis;Clinical Infectious Diseases;2022-11-04
5. Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens;Clinical Pharmacology & Therapeutics;2022-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3